Raj Maheshwari
Founder at Charlestown Capital Advisors LLC
Profile
Mr. Raj Maheshwari is a Chief Operating Officer at Cambelle-Inland LLC and a Managing Director at Charlestown Capital Advisors LLC.
He founded the firm Charlestown on August 2005.
Under his tenure, Charlestown Capital has been an M&A advisor to Esmark, Inc., a $1.3 billion steel company that was sold to OAO Severstal of Russia in August 2008.
Prior to Charlestown, Mr. Maheshwari was a portfolio manager and managing director at Weiss Peck and Great Investments.
From 1999 to August 2005, Mr. Maheshwari was a Portfolio Manager and Managing Director at WPG and its successor parent company Robeco Investment Management.
At WPG, he built and managed a $500 million (approximately) Risk Arbitrage and Special Situations/Event Driven hedge fund.
In Addition, at WPG and its parent company, Robeco Investment Management, he was involved in many aspects of investment management, including asset allocation, identifying new investment strategies, and overall new investment strategy.
From 1996 to 1999, Mr. Maheshwari was a Vice President of Research at Robert Fleming, Inc., where he helped run a $250 million (approximately) equity portfolio.
Mr. Maheshwari holds a BS in Mathematics and Computer Sciences from the State University of New York at Albany and an MBA from New York University.
Raj Maheshwari active positions
| Companies | Position | Start |
|---|---|---|
Charlestown Capital Advisors LLC
 Charlestown Capital Advisors LLC Investment ManagersFinance Charlestown Capital Advisors LLC is a private equity firm located in the Financial District of New York City. The American company provides merchant banking, financial advisory, and M & A investment services. It was founded in 2005 by Raj Maheshwari. | Founder | 2005-07-31 |
| Cambelle-Inland LLC | Chief Operating Officer | 2013-08-31 |
Former positions of Raj Maheshwari
| Companies | Position | End |
|---|---|---|
| ELAH HOLDINGS, INC. | Director/Board Member | 2017-10-07 |
Akela Pharma, Inc.
 Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Akela Pharma, Inc. operates as a drug development company, which develops and manufactures pharmaceutical formulations and drugs. The company operates as a specialty contract pharmaceutical formulation developer and clinical and commercial drug manufacturer for proprietary drug products through its wholly-owned subsidiary, PharmaForm LLC, a pharmaceutical intellectual property development company. It provides specialty contract services in the area of pharmaceutical dosage form development, preclinical, scale-up, clinical and commercial supply manufacturing, focusing on controlled release and bioavailability enhancement technologies, such as hot melt extrusion, spray drying and liquid filled capsules. Akela Pharma was founded on November 15, 1988 and is headquartered in Austin, TX. | Director/Board Member | 2009-10-18 |
Robeco Weiss, Peck & Greer Investments
 Robeco Weiss, Peck & Greer Investments Investment ManagersFinance A subsidiary of Robeco Investment Management, Robeco Weiss, Peck & Greer Investments is an investment adviser headquartered in New York City with an additional office in Menlo Park, California. The firm was founded in 1970. Their ultimate parent is Cooperative Centrale Raiffeisen Boerenleenbank. | Portfolio Manager-Equities | 2005-01-30 |
| Robert Fleming, Inc. | Corporate Officer/Principal | 1998-12-31 |
Training of Raj Maheshwari
| New York University | Masters Business Admin |
| State University of New York at Albany | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ELAH HOLDINGS, INC. | Finance |
| Private companies | 5 |
|---|---|
Robeco Weiss, Peck & Greer Investments
Robeco Weiss, Peck & Greer Investments Investment ManagersFinance A subsidiary of Robeco Investment Management, Robeco Weiss, Peck & Greer Investments is an investment adviser headquartered in New York City with an additional office in Menlo Park, California. The firm was founded in 1970. Their ultimate parent is Cooperative Centrale Raiffeisen Boerenleenbank. | Finance |
| Robert Fleming, Inc. | Finance |
Akela Pharma, Inc.
Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Akela Pharma, Inc. operates as a drug development company, which develops and manufactures pharmaceutical formulations and drugs. The company operates as a specialty contract pharmaceutical formulation developer and clinical and commercial drug manufacturer for proprietary drug products through its wholly-owned subsidiary, PharmaForm LLC, a pharmaceutical intellectual property development company. It provides specialty contract services in the area of pharmaceutical dosage form development, preclinical, scale-up, clinical and commercial supply manufacturing, focusing on controlled release and bioavailability enhancement technologies, such as hot melt extrusion, spray drying and liquid filled capsules. Akela Pharma was founded on November 15, 1988 and is headquartered in Austin, TX. | Health Technology |
| Cambelle-Inland LLC | |
Charlestown Capital Advisors LLC
Charlestown Capital Advisors LLC Investment ManagersFinance Charlestown Capital Advisors LLC is a private equity firm located in the Financial District of New York City. The American company provides merchant banking, financial advisory, and M & A investment services. It was founded in 2005 by Raj Maheshwari. | Finance |
- Stock Market
- Insiders
- Raj Maheshwari
